Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

03-Feb-20 - 31-Jan-21
Buy Ratio:32%

Down

# Net Buyers:83
# Net Sellers:173

Previous 52 Weeks

04-Feb-19 - 02-Feb-20
Buy Ratio:40%
# Net Buyers:110
# Net Sellers:166
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Loxo Oncology, Inc.--$561.91M  
Aimmune Therapeutics, Inc.$289.74M$289.63M  
Osiris Therapeutics, Inc.--$281.65M  
Spark Therapeutics, Inc.--$255.52M  
Dicerna Pharmaceuticals Inc($30.62M)$132.58M  
New Net Buyers
CompanyNet Buy AmountChange
Vertex Pharmaceuticals Inc / Ma$2.25M$91.01M  
Alexion Pharmaceuticals, Inc.$2.25M$45.67M  
Kalvista Pharmaceuticals, Inc.$315.71K$34.98M  
Pdl Biopharma, Inc.$27.57M$28.63M  
Charles River Laboratories International, Inc.$477.99K$26.26M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals, Inc.($1.24B)($913.27M)  
Seagen Inc.($615.63M)($571.19M)  
Catalent, Inc.($580.32M)($552.26M)  
Vaxart, Inc.($322.59M)($325.21M)  
Five Prime Therapeutics, Inc.($147.25M)($160.01M)  
New Net Sellers
CompanyNet Buy AmountChange
Vaxart, Inc.($322.59M)($325.21M)  
Five Prime Therapeutics, Inc.($147.25M)($160.01M)  
Amyris, Inc.($8.16M)($129.97M)  
Intercept Pharmaceuticals, Inc.($122.22M)($122.32M)  
Xbiotech Inc.($34.10M)($44.37M)